{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:40:38Z","timestamp":1790458838949,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":795,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1593\/neo.111570","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:01:18Z","timestamp":1429794078000},"page":"228-237","source":"Crossref","is-referenced-by-count":60,"title":["Rapamycin Inhibits Lymphatic Endothelial Cell Tube Formation by Downregulating Vascular Endothelial Growth Factor Receptor 3 Protein Expression"],"prefix":"10.1016","volume":"14","author":[{"given":"Yan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Odaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Steven","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shile","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.111570_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"Lohela","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1593\/neo.111570_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/092986710790514471","article-title":"Targeting tumor lymphangiogenesis: an update","volume":"17","author":"Raica","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1593\/neo.111570_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/BST0390431","article-title":"mTOR signalling in health and disease","volume":"39","author":"Proud","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1593\/neo.111570_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1593\/neo.111570_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol Cell"},{"key":"10.1593\/neo.111570_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1593\/neo.111570_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1593\/neo.111570_bib8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1097-2765(03)00114-X","article-title":"G\u03b2L, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR","volume":"11","author":"Kim","year":"2003","journal-title":"Mol Cell"},{"key":"10.1593\/neo.111570_bib9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","article-title":"PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase","volume":"25","author":"Sancak","year":"2007","journal-title":"Mol Cell"},{"key":"10.1593\/neo.111570_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncb1547","article-title":"Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40","volume":"9","author":"Vander Haar","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1593\/neo.111570_bib11","doi-asserted-by":"crossref","first-page":"24514","DOI":"10.1074\/jbc.M704406200","article-title":"PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex","volume":"282","author":"Fonseca","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.111570_bib12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.1593\/neo.111570_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1593\/neo.111570_bib14","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1593\/neo.111570_bib15","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","article-title":"mSin1 is necessary for Akt\/PKB phosphorylation, and its isoforms define three distinct mTORC2s","volume":"16","author":"Frias","year":"2006","journal-title":"Curr Biol"},{"key":"10.1593\/neo.111570_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"10.1593\/neo.111570_bib17","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1101\/gad.1461206","article-title":"Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity","volume":"20","author":"Yang","year":"2006","journal-title":"Genes Dev"},{"key":"10.1593\/neo.111570_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/BJ20070540","article-title":"Identification of Protor as a novel Rictor-binding component of mTOR complex-2","volume":"405","author":"Pearce","year":"2007","journal-title":"Biochem J"},{"key":"10.1593\/neo.111570_bib19","doi-asserted-by":"crossref","first-page":"25604","DOI":"10.1074\/jbc.M704343200","article-title":"PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor \u03b2 expression and signaling","volume":"282","author":"Woo","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.111570_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20081668","article-title":"mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum-and glucocorticoid-induced protein kinase 1 (SGK1)","volume":"416","author":"Garc\u00eda-Mart\u00ednez","year":"2008","journal-title":"Biochem J"},{"key":"10.1593\/neo.111570_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"key":"10.1593\/neo.111570_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1042\/BST0390446","article-title":"Differing effects of rapamycin and mTOR kinase inhibitors on protein synthesis","volume":"39","author":"Huo","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1593\/neo.111570_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002112","article-title":"Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis","volume":"71","author":"Huber","year":"2007","journal-title":"Kidney Int"},{"key":"10.1593\/neo.111570_bib24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1349-7006.2007.00439.x","article-title":"Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis","volume":"98","author":"Kobayashi","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1593\/neo.111570_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mvr.2009.02.007","article-title":"IL-20 activates human lymphatic endothelial cells causing cell signalling and tube formation","volume":"78","author":"Hammer","year":"2009","journal-title":"Microvasc Res"},{"key":"10.1593\/neo.111570_bib26","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","article-title":"Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development","volume":"92","author":"Kaipainen","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.111570_bib27","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1242\/dev.122.12.3829","article-title":"VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development","volume":"122","author":"Kukk","year":"1996","journal-title":"Development"},{"key":"10.1593\/neo.111570_bib28","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1093\/emboj\/20.17.4762","article-title":"Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C\/D receptor VEGFR-3","volume":"20","author":"M\u00e4kinen","year":"2001","journal-title":"EMBO J"},{"key":"10.1593\/neo.111570_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/84651","article-title":"Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3","volume":"7","author":"M\u00e4kinen","year":"2001","journal-title":"Nat Med"},{"key":"10.1593\/neo.111570_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jnci\/94.11.819","article-title":"Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling","volume":"94","author":"He","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.111570_bib31","first-page":"713","article-title":"Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats","volume":"63","author":"Krishnan","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111570_bib32","doi-asserted-by":"crossref","first-page":"15593","DOI":"10.1073\/pnas.0507865102","article-title":"Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo","volume":"102","author":"Bj\u00f6rndahl","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.111570_bib33","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/onc.2010.17","article-title":"Inhibition of cancer cell proliferation and metastasis by insulin receptor down-regulation","volume":"29","author":"Zhang","year":"2010","journal-title":"Oncogene"},{"key":"10.1593\/neo.111570_bib34","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/onc.2010.590","article-title":"The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway","volume":"30","author":"Luo","year":"2011","journal-title":"Oncogene"},{"key":"10.1593\/neo.111570_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/lrb.2005.3.117","article-title":"Homogeneity of mesothelial cells with lymphatic endothelium: expression of lymphatic endothelial markers by mesothelial cells","volume":"3","author":"Ando","year":"2005","journal-title":"Lymphat Res Biol"},{"key":"10.1593\/neo.111570_bib36","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/ijc.25255","article-title":"The antitumor activity of the fungicide ciclopirox","volume":"127","author":"Zhou","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.111570_bib37","doi-asserted-by":"crossref","first-page":"38362","DOI":"10.1074\/jbc.M110.141168","article-title":"Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity","volume":"285","author":"Liu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.111570_bib38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.freeradbiomed.2010.12.032","article-title":"Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death","volume":"50","author":"Chen","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1593\/neo.111570_bib39","doi-asserted-by":"crossref","first-page":"36079","DOI":"10.1074\/jbc.C100406200","article-title":"The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism","volume":"276","author":"Erbay","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.111570_bib40","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1\u03b1 expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111570_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1593\/neo.111570_bib42","first-page":"1786","article-title":"Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth","volume":"61","author":"Karpanen","year":"2001","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111570_bib43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2353\/ajpath.2006.051200","article-title":"Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation","volume":"169","author":"Karpanen","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.111570_bib44","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1158\/0008-5472.CAN-05-0408","article-title":"Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor","volume":"65","author":"Lin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111570_bib45","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1158\/0008-5472.CAN-04-4576","article-title":"Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels","volume":"65","author":"He","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111570_bib46","first-page":"5978","article-title":"CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models","volume":"63","author":"Ruggeri","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111570_bib47","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1073\/pnas.062040199","article-title":"Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea","volume":"99","author":"Kubo","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.111570_bib48","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1073\/pnas.0404272101","article-title":"Dose-dependent response of FGF-2 for lymphangiogenesis","volume":"101","author":"Chang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.111570_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2004.08.034","article-title":"PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis","volume":"6","author":"Cao","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.111570_bib50","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/sj.emboj.7600763","article-title":"Hepatocyte growth factor promotes lymphatic vessel formation and function","volume":"24","author":"Kajiya","year":"2005","journal-title":"EMBO J"},{"key":"10.1593\/neo.111570_bib51","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1210\/endo.137.6.8641174","article-title":"Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I","volume":"137","author":"Goad","year":"1996","journal-title":"Endocrinology"},{"key":"10.1593\/neo.111570_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.molcel.2011.08.030","article-title":"mTOR drives its own activation via SCF (\u03b2TrCP)-dependent degradation of the mTOR inhibitor DEPTOR","volume":"44","author":"Gao","year":"2011","journal-title":"Mol Cell"},{"key":"10.1593\/neo.111570_bib53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.molcel.2011.08.029","article-title":"DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(\u03b2TrCP) E3 ubiquitin ligase and regulates survival and autophagy","volume":"44","author":"Zhao","year":"2011","journal-title":"Mol Cell"},{"key":"10.1593\/neo.111570_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molcel.2011.09.005","article-title":"mTOR generates an auto-amplification loop by triggering the \u03b2TrCP- and CK1\u03b1-dependent degradation of DEPTOR","volume":"44","author":"Duan","year":"2011","journal-title":"Mol Cell"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558612800352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558612800352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T22:43:27Z","timestamp":1651790607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558612800352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1476558612800352"],"URL":"https:\/\/doi.org\/10.1593\/neo.111570","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}